Parth Shah @ParthSharesBio
Biotech exec sharing views on biopharma | Passionate about #leadership and advancing medicines to reach patients | #RareDisease | Tweets are my own | 🤝 linkedin.com/in/parthrshah California, USA Joined September 2013-
Tweets242
-
Followers227
-
Following218
-
Likes733
As competitive as oncology if not more on the high side…#immunology #oncology #biotech #pharma #drugdevelopment
As competitive as oncology if not more on the high side…#immunology #oncology #biotech #pharma #drugdevelopment
$VRTX has $23.4M Mkt Cap for Every Employee ! Source: Stifel
Biotech Consolidation: Not Really Happening. After two years of talk, that appears to be all it is right now… talk. Net numbers of publicly traded biotech down only 4.5%, hardly significant. lifescivc.com/2023/11/biotec…
One of the most powerful things we do at Amgen is to take the time to celebrate our shared mission for patients and recognize the work that we all do matters. Truly an inspiring day being with our team and hearing directly from the patients we serve. #AmgenMissionWeek #mycompany…
We set up the molecules in our portfolio as little companies and each one of those companies has a leadership team and board of directors. And they'll meet whenever they need to—and that's the way we provide the governance instead of the teams coming to committees for approvals.
RNAi (Alnylam), ASO (Ionis), Human Mabs (Regeneron), rDNA (Genentech, Biogen, many others)… Platforms are the only way to achieve sustainable innovation.
RNAi (Alnylam), ASO (Ionis), Human Mabs (Regeneron), rDNA (Genentech, Biogen, many others)… Platforms are the only way to achieve sustainable innovation.
2023 Orphan Drugs: PDUFA Dates and FDA Approvals Click on the link below👇 to view the list of important regulatory dates for all orphan drugs for 2023. checkrare.com/2023-orphan-dr… #rarediseases #drugapprovals
The lessons we learn over and over.
The lessons we learn over and over.
The “Innovation Reduction Act?” An inspiring story by Dr. Ted Love. The #InflationReductionAct has some laudable provisions, but others that threaten to chill investment in the new #medicines we and our loved ones all need.
The “Innovation Reduction Act?” An inspiring story by Dr. Ted Love. The #InflationReductionAct has some laudable provisions, but others that threaten to chill investment in the new #medicines we and our loved ones all need.
Great contrarian take on eNPV in #drugdevelopment . But this is where the people and process beyond the data are critical in these high stakes decisions. The best leaders know when to take the eNPV off the table, or use it as an extra data point at most. You can often make a…
Great contrarian take on eNPV in #drugdevelopment . But this is where the people and process beyond the data are critical in these high stakes decisions. The best leaders know when to take the eNPV off the table, or use it as an extra data point at most. You can often make a…
An important #FDA consideration if you are navigating upcoming #clinicaldevelopment in #RareDisease. Double edge sword as some of cross disease instruments may not yield all the disease specific nuances. Looking forward to more updates about the endpoint advancement program...…
Development and commercial odds are tough which is why the mission/vision is so critical —> the inspiration to do the unimaginable isn’t just make believe - time and again , we have seen that if you can stay in the commercialization fight, you’ll land some blows, but the team…
Development and commercial odds are tough which is why the mission/vision is so critical —> the inspiration to do the unimaginable isn’t just make believe - time and again , we have seen that if you can stay in the commercialization fight, you’ll land some blows, but the team…
AstraZeneca will buy up a group of early-stage gene therapies from Pfizer, bucking a trend of drugmakers axing programs and exiting a field that had once captured the imagination — and checkbooks — of many pharmaceutical executives. trib.al/78WHgKb
Better use of digital and data in rare disease commercialization go hand in hand. However, applying judgment to these levers and creating an intentional strategy and org design to execute is the tough part (my brief take 👇). #pharma #biotech mckinsey.com/industries/lif…
Great clip from @chamath describing who the ultimate financial winners may be from the generative AI revolution
Came across NaviHealth recently denying care to a 33-year old mom with a rare ovarian cancer. Drug was working but new #PBM using NaviHealth denied it. Report in @statnews @caseymross @bobjherman statnews.com/2023/03/13/med…
#Hospitals took $28 Billion in tax-exemptions for charity care but delivered only $16B in care-while they set collectors on indigent patients who couldn't afford their bills. Why are @POTUS & #Congress not exercised about this? #healthcare #costs
#Hospitals took $28 Billion in tax-exemptions for charity care but delivered only $16B in care-while they set collectors on indigent patients who couldn't afford their bills. Why are @POTUS & #Congress not exercised about this? #healthcare #costs
VeraHarrison @A1BG11kA3qEJz9
0 Followers 36 Following
Slesher @Sleshermzd3po
0 Followers 72 Following
Laurena Wieben @wie_laur
50 Followers 5K Following
Diane Song @song_diane1
0 Followers 18 Following
Librada Kraham @KrahLibra
30 Followers 5K Following
Chau Boberg @BobergChau95939
23 Followers 5K Following
Desire Dermody @DesiDermo
80 Followers 5K Following
Dotty Johannsen @DottyJohan16814
78 Followers 5K Following
Roni Charter @CharterRon34871
85 Followers 5K Following
Effie Froio @EffieFroio37404
98 Followers 5K Following
Shirley Sanez @shirley79417
69 Followers 5K Following
Jana Poniatowski @PoniatowskJan
17 Followers 3K Following
Kimber Morlas @kimber46521
81 Followers 5K Following
Chu Ocanaz @COcanaz31291
75 Followers 5K Following
Antonette Fisette @AntonetteF88485
95 Followers 5K Following
Francesca Thim @FrancescaT86230
57 Followers 5K Following
Azra Markey @marke_azr
34 Followers 5K Following
Bubba @AConfidenceGame
293 Followers 476 Following It’s only money, until you pull out your wheelbarrow to pay your landlord.
Selina Lennon @lennon_seli
38 Followers 5K Following
Margene Schnabel @MargeSchna
46 Followers 5K Following
Daisey Twardy @DaiseyTwa
46 Followers 5K Following
Leta Jutras @jutras_le
53 Followers 5K Following
AttractiveSkew @AttractiveSkew
133 Followers 1K Following you just got indiscriminately AI/GLP1-ed. opinions are my own
Matthew Palmer @Matt_Palmer_RnD
4 Followers 23 Following Talent partner to the world's leading Targeted Cancer Therapy biotech companies.
Lavonne @mcraney_lavonne
935 Followers 3K Following
Cheyanne Davenport @cheyanne89374
137 Followers 3K Following
Vaneet K Sandhu, MD, .. @vksandhumd
1K Followers 359 Following (pronounced VUH-neet sun-dhoo) Mother. She/Her/Hers. Rheumatologist. Biotech Sr Medical Director. Tweets are not medical advice.
Lynn Yao @LynnYaofree
0 Followers 12 Following
Brenda @brendalewis21
158 Followers 3K Following
Anand C. Patel, MD MS @anandcpatelmdms
1K Followers 3K Following Pediatric pulmonologist and bioinformaticist, now in drug development. He/him. https://t.co/61YX7H46Pc @PioneeringMeds https://t.co/LqrSTRsx0C too
Rare Disease Advisor @RareDisease_Adv
5K Followers 1K Following Trusted knowledge base of practical information and resources focused on treating and diagnosing #RareDisease.
Sell international ac.. @js7kw2LL0A95177
493 Followers 5K Following Sell Hong Kong international accounts and receive various currencies from around the world. TG:lanyingcao V:LL1689527 香港个人户公司户出售定做，合作跑量
HealthQuant @HealthQuant
338 Followers 1K Following REAL Physician Influence. Time to bring your KOL programming into the digital age! Tweets by @chimoose
Ron Renaud @biotech1969
2K Followers 776 Following Biotech. Husband, father of two and fan of all things Boston and USC! Tweets are my own!
Ashoka Madduri @ashokamadduri
306 Followers 1K Following BioPharma Strategy | @MITSloanAlumni | ex @Harvard PostDoc | @UnivGroningen alumni | Opinions are my own
Rachel King @RachelKingBio
163 Followers 115 Following Mother. Grandma. Wife. CEO @iambiotech. Aspiring Chef. Part Time Foodie. Lets go duke!🏀 #IamBIO
Peter Halliburton @phalliburton
3K Followers 2K Following Raising $$ for #SYNGAP1 gene therapy 🧬 // @cureSYNGAP1 501(c)(3) Board // Carter & Presley’s Dad // @lindsayhalli 💜 // @cyberark Channel
Partnership to Fight .. @pfcd
2K Followers 2K Following News and information on the fight against the number one cause of death, disability, and rising health care costs: chronic disease.
Jake Parker @ingeneousmachin
775 Followers 2K Following Protein engineering @YakkaBio. Working on a next-gen ADC NewCo 👀 — structured loops and buried polar groups are a feature, not a bug.
Jake Weber @BioStockAnalyst
4K Followers 734 Following Biotech stock analyst. Editor of Biotech Millionaire at Mauldin Economics. Tweets and opinions are not investment advice.
CG Oncology, Inc. @cgoncology
296 Followers 274 Following CG Oncology is a clinical-stage immuno-oncology company focused on the development of oncolytic immunotherapies to combat cancer
KenWarringtonMD @MdWarrington
3K Followers 963 Following Professor and Rheumatologist l Vasculitis Clinic Director @MayoClinic Rochester | Researcher #vasculitis #rheumatology #MayoClinicRheumatology #travel 🇲🇹🇺🇸
Adam Kilian MD @KilianMD
2K Followers 1K Following #Rheumatologist, board-certified physician, researcher, patient advocate, educator & director #rheumatology fellowship program at @SLUcare & @SLUSOM
Anisha Dua @anisha_dua
2K Followers 199 Following Program Director of Rheumatology @NorthwesternMed. Interested in #MedEd and #vasculitis. Views are my own.
Rare Disease Advisor @RareDisease_Adv
5K Followers 1K Following Trusted knowledge base of practical information and resources focused on treating and diagnosing #RareDisease.
Matthew Palmer @Matt_Palmer_RnD
4 Followers 23 Following Talent partner to the world's leading Targeted Cancer Therapy biotech companies.
Jay Bradner, M.D. @jaybradner
22K Followers 938 Following Physician-scientist making medicines with friends, memories with family. EVP R&D and CSO at Amgen
Ross V. Chikarmane @rvchikar
429 Followers 1K Following 🧬 Biotech Investor at RA Capital | scientist 🧪, capitalist 📈, hot take connoisseur🌶️🌶️, 🇺🇲 🇬🇧 | 🔬 PhD @HopkinsMedicine | Views my own
Sara Nayeem @SaraNayeem
11K Followers 2K Following Invest in emerging biopharma co's as EVP, Investments at Enavate Sciences. Prior NEA and Avoro Ventures. I post advice for biopharma exec's and emerging VCs.
Raleigh Williams (Exi.. @theraleighwill
13K Followers 1K Following Ex M&A Lawyer. Sold a trampoline park business for 8 figures. Building a $50M portfolio of Side Bets and writing about how to find yours.
Vaneet K Sandhu, MD, .. @vksandhumd
1K Followers 359 Following (pronounced VUH-neet sun-dhoo) Mother. She/Her/Hers. Rheumatologist. Biotech Sr Medical Director. Tweets are not medical advice.
Anand C. Patel, MD MS @anandcpatelmdms
1K Followers 3K Following Pediatric pulmonologist and bioinformaticist, now in drug development. He/him. https://t.co/61YX7H46Pc @PioneeringMeds https://t.co/LqrSTRsx0C too
Michael Tal Sharon @tseworldwide
1K Followers 5K Following #AmYisraelChai #soccer #Biotech #oncology #precisionmedicine #immunotherapy #genetherapy #AI #CraftBeer https://t.co/BZfewcOc1q…
Emma J Chory @chorye
4K Followers 2K Following Assistant professor @Duke, guerilla knitter, pipettor of small volumes of liquid. Biologist masquerading as engineer, or the other way around.
FreeBioAlpha @freebioalpha
3K Followers 10 Following Open sourcing information to activate more talent in science. Powered by @axialxyz
PA Rare Disease Advis.. @PARareDisease
787 Followers 638 Following To improve the quality of life for all those affected by rare diseases in Pennsylvania.
Philip Hemme @PhilipHemme
6K Followers 230 Following Founder @FlotBio | Author | Founder @Labiotech_eu (exit) | Bioengineer
The Flot.bio Show @FlotBio
94 Followers 39 Following Watch the best Europeans in biotech to grow. Hosted by @PhilipHemme. 15k monthly views. Free.
CheckRare @CheckRare
3K Followers 2K Following Leading publisher and learning platform focused on rare diseases. Rare Diseases Are Our Focus, Expertise, and Passion.
Rare Disease Innovati.. @rdii_org
448 Followers 214 Following RDII is a non-profit organization focused on education, engagement and to equip the rare disease community
Rare Disease and Orph.. @OAE_RDODJ
439 Followers 2K Following Rare Disease and Orphan Drugs Journal(RDODJ) is an international peer-reviewed, open access, online journal.
Annalee Armstrong @AGKootenay
2K Followers 711 Following Ex-pat Canadian from B.C.'s East Kootenay. I like puppies & wine | Senior Editor for @FierceBiotech
Peter Halliburton @phalliburton
3K Followers 2K Following Raising $$ for #SYNGAP1 gene therapy 🧬 // @cureSYNGAP1 501(c)(3) Board // Carter & Presley’s Dad // @lindsayhalli 💜 // @cyberark Channel
Jake Parker @ingeneousmachin
775 Followers 2K Following Protein engineering @YakkaBio. Working on a next-gen ADC NewCo 👀 — structured loops and buried polar groups are a feature, not a bug.
Global Kidney Academy @GKA_CME
605 Followers 700 Following The Global Kidney Academy (GKA) is an educational program for physicians and other healthcare professionals involved in nephrology.
Rare Disease Advisor .. @rda_aav
25 Followers 26 Following Follow Rare Disease Advisor's ANCA-associated Vasculitis Junction for the latest news, perspectives, and resources about the disease.
Demy Colton @demycolton
3K Followers 2K Following Demy-Colton produces highly specialized targeted investor conferences exclusively for the biopharma, life sciences and digital health industry.
Biotech Tailwind Capi.. @BiotechTailwind
93 Followers 155 Following Investor Relations / Corporate Comms / ex #WallSt. Connecting #biotech / #medtech to specialist #investors. ❤️#InvestorRelations #VC #JPM24 #JPMWeek
biobrain @biobrainbox
333 Followers 440 Following Lapsed Liverpudlian & former Neuroscientist. Rare disease and Neurology expertise plus CDMO insight. Interested in the intangibles of R&D success.
Ashoka Madduri @ashokamadduri
306 Followers 1K Following BioPharma Strategy | @MITSloanAlumni | ex @Harvard PostDoc | @UnivGroningen alumni | Opinions are my own
Saurabh Sewak @SaurabhSewak
71 Followers 522 Following Intersection of business and science in Biotech. Aspiring to cure cancer. Tweets are my own opinions and not an endorsement .
Stuart Blitz @StuartBlitz
6K Followers 4K Following Co-Founder/COO @HoneHealth, formerly CBO @7SBio, @AgaMatrix, travel guru, consumer health tech, helper
Biotech Investor @learnbiotech
2K Followers 307 Following Learn to invest in biotech like the professionals from a former biotech executive and investment banker Course on Thinkific
Rachel King @RachelKingBio
163 Followers 115 Following Mother. Grandma. Wife. CEO @iambiotech. Aspiring Chef. Part Time Foodie. Lets go duke!🏀 #IamBIO
Jake Weber @BioStockAnalyst
4K Followers 734 Following Biotech stock analyst. Editor of Biotech Millionaire at Mauldin Economics. Tweets and opinions are not investment advice.
Partnership to Fight .. @pfcd
2K Followers 2K Following News and information on the fight against the number one cause of death, disability, and rising health care costs: chronic disease.
BiotechBioPharma @Regencells
2K Followers 2K Following A biotech/biopharma small cap and trends media channel for Content Carnivores.
South Dakota Biotech @SoDakBiotech
980 Followers 495 Following The SD Biotech Association is a member-based non-profit that seeks to create an expansive bio-based economy in South Dakota. #sdbio18
Ruby Gadelrab @DivaBiotech
10K Followers 8K Following CEO and Founder of @M_Disrupt, Healthcare Executive #Genomics #DigitalHealth expert, ex VP Commercial Marketing @23andme, advisor, mentor.
Ron Renaud @biotech1969
2K Followers 776 Following Biotech. Husband, father of two and fan of all things Boston and USC! Tweets are my own!
Endure_Rare 💙💚�.. @Endure_Rare
922 Followers 901 Following SYNGAP Dad, Clinical Lab Professional & Triathlete 140.6 living life with grace and peace knowing "someone's worst day is someone's best" #Syngap1 @cureSynGAP1
CureKCNH1 @CureKCNH1
139 Followers 218 Following Cure KCNH1 Foundation is dedicated to advancing the development of treatments for children with KCNH1 genetic disorders. https://t.co/JYCIrztO3N
SHINE Syndrome @SHINESyndrome
204 Followers 194 Following DLG4 Synaptopathy / SHINE Syndrome *Managed by the board of the SHINE Syndrome Foundation
Curedlg4 @curedlg4
71 Followers 126 Following We are a small non-profit whose central goal is to support the research and development of treatments, therapies, and support systems for individuals with DLG4
CG Oncology, Inc. @cgoncology
296 Followers 274 Following CG Oncology is a clinical-stage immuno-oncology company focused on the development of oncolytic immunotherapies to combat cancer
Drug Target Review @DrugTargetRev
5K Followers 4K Following Drug Target Review is the leading FREE publication for the drug discovery industry, promoting the latest research, developments & technology.
Greg Matthews @chimoose
20K Followers 16K Following REAL Physician Influence @HealthQuant. KOL Identification & Strategy. Social analytics pioneer. Advisor: @MayoClinic SMN, @SxSW, @TXHlthCatalyst.
This is fundamental misunderstanding many have about medicine. Diseases have heterogeneous pathology, especially in cancer. Expecting drugs to work for every patient is just not reflective of biology.
Reading Between the Transaction Timelines by Cantor **2023 Acquisitions Maintains that Many Deals Are Competitive
T-Cell Driven Autoimmunity Pipeline: **This reminds me of early days of CAR-T landscape
Immunology Target Space: 60% of programs are in fields with six or more programs Source: Stifel
$VRTX has $23.4M Mkt Cap for Every Employee ! Source: Stifel
New professor walking to lecture on her first day of class. Wish me/them luck! (But mainly me)
Do NOT jump from an MBA to try to start your own biotech company. Do NOT jump into a small start up. Do NOT skip experience in a big biotech (where you will learn from great people) and think you can develop drugs when you’ve never seen it done. 🧵7
Do NOT rush and miss out on the experience you need to be successful! Experience is PRICELESS! Hope this helps! John P.S. Also, don’t do virtual or hybrid “work!” Be on site!!! 🧵8/8
Bob Bradway announced today that I have joined his leadership team as Executive Vice President of R&D, and Chief Scientific Officer @Amgen. I am overjoyed by the opportunity to create and develop therapeutic solutions for patients with serious illnesses. Here are some additional…
We’re announcing two changes to Amgen’s senior leadership team that will keep our company at the forefront of innovation. @jaybradner, M.D., joins as EVP, R&D, and Chief Scientific Officer. David M. Reese, M.D., will assume a new role as EVP and Chief Technology Officer.…
Let’s go! @Amgen #MyCompany
No wonder my day was super busy with investors wanting to schedule meetings 🤦♀️ #JPM24 #biotech #medtech #InvestorRelations
The preliminary #JPM24 schedule is out.
My PhD advisor and an amazing mentor. Learned so much from him, not just about science but life in general. Sad day. RIP.
A major loss for all of us. Allan Hoffman (1932-2023) Univ_Washington passed away today. Allan was my academic brother (PhD '57 MIT) and great mentor. Devastated. He was such an inspiration to all of us. All in tears after we received the news about an hour ago. RIP.
completed $148M raise ($125M offering, $23M private placement with @EliLillyandCo) post raise, 3y cash runway, now into late 2026. @VerveTx $VERV ir.vervetx.com/news-releases/…
Biotech startups with a large pharma investor/licensor have a higher success rate (32% vs 18% aquisition/IPO/FDA approval rate) and higher valuations, as measured by current market capitalization (median $332M vs $138M market cap; median $337 million vs $138M acquisition value).
How large pharma impacts biotech startup success. Implications for bioentrepreneurs go.nature.com/3djFeZm rdcu.be/cgdw5
@LifeSciVC Biopharma is unconcentrated to begin with, vs other sectors...and there are *tons* of companies! Interesting that the # of companies is relatively stable Y/Y (-4.5%) vs >20% reduction for the GFC. There's prob more consolidation in mkt cap terms, but that's harder to pin down.
Biotech Consolidation: Not Really Happening. After two years of talk, that appears to be all it is right now… talk. Net numbers of publicly traded biotech down only 4.5%, hardly significant. lifescivc.com/2023/11/biotec…
Today I started a new role as EVP, Investments at Enavate Sciences (part of Patient Square Capital). I'm thrilled to be working with the stellar team at Enavate to identify new biopharma investment opportunities, and w/ the talented entrepreneurs at their portfolio companies!
Last 5 years @VerveTx What will next 5y bring? Super excited for path ahead with our team
A common theme in my work with biotech leaders is tough conversations. How can you confidently have a tough conversation in which you openly ask for what you need without damaging your relationship with the other person? I've written a long thread with a step-by-step framework…
🚀Coming soon: All my most loved articles and guides on biotech leadership in a single book! 📕 Boy, have I written a lot this year! Endless hours of researching, writing, editing, re-editing… And now, putting all these writings into a book hasn’t been easy either! I wasn’t…
Trends for United States
You might like
